Gut bacteria can interfere with the main treatment of Parkinson's disease

Published in Microbiology
Gut bacteria can interfere with the main treatment of Parkinson's disease
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Patients with Parkinson’s Disease are treated with levodopa, which is converted into the neurotransmitter dopamine in the brain. In a study that was published on 18 January in Nature Communications, we show that gut bacteria can metabolise levodopa into dopamine. As dopamine cannot cross the blood-brain barrier, this means the bacteria can compromise the availability of the medication, even in the presence of inhibitors that should prevent the conversion of levodopa. Check it at: https://www.nature.com/articles/s41467-019-08294-y

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Microbiology
Life Sciences > Biological Sciences > Microbiology

Related Collections

With collections, you can get published faster and increase your visibility.

Applications of Artificial Intelligence in Cancer

In this cross-journal collection between Nature Communications, npj Digital Medicine, npj Precision Oncology, Communications Medicine, Communications Biology, and Scientific Reports, we invite submissions with a focus on artificial intelligence in cancer.

Publishing Model: Open Access

Deadline: Mar 31, 2025

Biology of rare genetic disorders

This cross-journal Collection between Nature Communications, Communications Biology, npj Genomic Medicine and Scientific Reports brings together research articles that provide new insights into the biology of rare genetic disorders, also known as Mendelian or monogenic disorders.

Publishing Model: Open Access

Deadline: Apr 30, 2025